BLOG

COVID-19 vaccines — minus the needle? Researchers working on capsules, nasal sprays

According to FasterCures, which is tracking 326 COVID-19 treatments and 252 vaccines, five companies are developing oral vaccines, and two — ImmunityBio and Vaxart — have progressed to Phase 1 clinical trials.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}